Therapeutic efficacy of oral ketamine in obsessive compulsive disorder
- Conditions
- Health Condition 1: F42- Obsessive-compulsive disorder
- Registration Number
- CTRI/2021/09/036469
- Lead Sponsor
- GMC RH Patiala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Male and female patients aged 18-65 years with OCD diagnosed on DSM-5.
2. Patients who will be medically stable .
3. Patients who have given written informed consent.
1.History of chronic psychosis or drug induced psychosis of any kind.
2. Current DSM-5 diagnosis of drug abuse/dependence in the last six months and a negative drug screen at baseline.
3. Pregnant women, lactating mothers, surgically-sterile women or women who agree to continue using applicable birth control throughout the trial. All women of child-bearing potential must have a negative urine pregnancy test.
4. History of seizures, renal insufficiency or congestive heart failure.
5. History of Ketamine abuse/dependence or prior clinically significant adverse reaction to ketamine.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method